Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study-Reference-Cited by-同舟云学术

Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study

Published:2016-05 Issue:3 Volume:20 Page:393-402
ISSN:1090-3798
Container-title:European Journal of Paediatric Neurology
language:en
Short-container-title:European Journal of Paediatric Neurology

Author:

Arzimanoglou Alexis^ORCID,Ferreira Jose A.,Satlin Andrew,Mendes Shannon,Williams Betsy,Critchley David^ORCID,Schuck Edgar,Hussein Ziad,Kumar Dinesh,Dhadda Shobha,Bibbiani Francesco^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Pediatrics, Perinatology and Child Health

Reference27 articles.

1. BANZEL (rufinamide) prescribing information,2015

2. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome;Glauser;Neurology,2008

3. Lennox-Gastaut syndrome: an update on treatment;Carmant;Can J Neurol Sci,2012

4. Definition and natural history of Lennox-Gastaut syndrome;Camfield;Epilepsia,2011

5. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology;Arzimanoglou;Lancet Neurol,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Variability of Rufinamide and Stiripentol in Children With Refractory Epilepsy: A Retrospective Study of Therapeutic Drug Monitoring From the National Epilepsy Centers in Denmark and Norway;Therapeutic Drug Monitoring;2024-05-15

2. The new International League Against Epilepsy (ILAE) definition of Lennox-Gastaut syndrome: Practical implications and limitations;Journal of Clinical Neuroscience;2023-09

3. Growth-related effects of antiseizure medications are of concern in children with epilepsy;Drugs & Therapy Perspectives;2023-01-26

4. Sex differences in side effects of antiseizure medications in pediatric patients with epilepsy: A systematic review;Seizure;2022-11

5. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies;CNS Drugs;2022-10